FGAM
IMGN

Financial Gravity Asset Management’s Immunogen Inc IMGN Stock Holding History

Financial Gravity Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$493 – 1744
2022
Q4 		$493 Buy
+5
New +$27 ﹤0.01% 808

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Gravity Asset Management's IMGN Position: Q1 2023 in Review

Financial Gravity Asset Management sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 5 shares — an estimated $493 sold.

Financial Gravity Asset Management first reported a position in IMGN in Q4 2022 and held it in 1 quarter. The position peaked at $493 in Q4 2022. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

  • Financial Gravity Asset Management reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
  • Financial Gravity Asset Management sold 5 Immunogen Inc shares in Q1 2023, an estimated $493.
  • Financial Gravity Asset Management first reported a position in Immunogen Inc in Q4 2022 and held it in 1 quarter.
  • Financial Gravity Asset Management's Immunogen Inc position peaked at $493 in Q4 2022.
  • 190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Financial Gravity Asset Management's 13F filing for Q1 2023, filed 12 May 2023.